• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

53
27
26
25
25

COUNTRY

23
4
3
2
1

CATEGORIES

  • 29
  • 16
  • 11
  • 10
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

10
20
30
99

PUBLISHED

4
23
38
99

PRODUCT TYPE

99

Search "China Diabetes Market Report & Outlook For 2010-2015" returned 99 results.

Investigation Report on China's Metformin Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

July 2015
FROM

Investigation Report on China's Metformin Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

July 2015
FROM

Investigation Report on China's Repaglinide Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382...

July 2015
FROM

Investigation Report on China's Repaglinide Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

July 2015
FROM

Investigation Report on China's Insulin Glargine Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

May 2015
FROM

Investigation Report on China's Insulin Glargine Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

May 2015
FROM

Investigation Report on China's Acarbose Market, 2010-2019

Diabetes is one of the most important chronic non- communicable diseases that threaten the health of people around the world. According to the statistics of International Diabetes Federation (IDF),...

May 2015
FROM

Investigation Report on China's Acarbose Market, 2010-2019

Diabetes is one of the most important chronic non-communicable diseases that threaten the health of people around the world. According to the statistics of International Diabetes Federation (IDF), in...

May 2015
FROM

Investigation Report on China's Glipizide Market, 2010-2019

According to the statistics of the International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382...

July 2015
FROM

Investigation Report on China's Glimepiride Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382...

July 2015
FROM

Investigation Report on China's Glimepiride Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382...

July 2015
FROM

Investigation Report on China's Gliclazide Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382...

July 2015
FROM

Investigation Report on China's Gliclazide Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382...

July 2015
FROM

Investigation Report on China's Gliclazide Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382...

July 2015
FROM

Investigation Report on China's Gliquidone Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

July 2015
FROM

Investigation Report on China's Nateglinide Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382...

July 2015
FROM

Investigation Report on China's Nateglinide Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

July 2015
FROM

Investigation Report on China's Liraglutide Market, 2011-2019

As the economy develops and living standards improve, the Chinese people’s dietary pattern changes, resulting in excess eating. Meanwhile, the drop in physical activities leads to the increased obesity...

June 2015
FROM

Pharmaceutical Industry in China - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges

“Pharmaceutical Industry China – Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges”...

March 2014
FROM

BRIC Diabetes Drugs Market (2010-2015)

The prevalence of diabetes is on the rise across the globe due to increased life expectancy, changing lifestyles, and the rising incidence of obesity Brazil's diabetes drugs market is showing a double...

April 2010
FROM
Loading Indicator

Our Clients

Walgreen's Company Elanco Global Nu Skin Enterprises Kemin Industries, Inc. Suan Farma Inc. Metagenics, Inc.